Cargando…

Two-way traffic: aligning expectations with current realities in oncology. Mid-term ESMO Presidency considerations

Detalles Bibliográficos
Autor principal:	Tabernero, Josep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435243/ https://www.ncbi.nlm.nih.gov/pubmed/30962958 http://dx.doi.org/10.1136/esmoopen-2019-000494

Ejemplares similares

Applying the ESMO-Magnitude of Clinical Benefit Scale in real life
por: Ciardiello, Fortunato, et al.
Publicado: (2016)

The Canadian–US Relationship in the First Year of Biden’s Presidency: Expectations and Reality
por: Komkova, E. G.
Publicado: (2023)

Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
por: Dafni, Urania, et al.
Publicado: (2017)

ESMO Open—Cancer Horizons and the future of oncology
por: Zielinski, Christoph C
Publicado: (2016)

ESMO pays tribute to Professor José Baselga
por: Peters, S., et al.
Publicado: (2021)

ESMO pays tribute to Professor José Baselga
por: Peters, S., et al.
Publicado: (2021)

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)
por: Morgan, Gilberto, et al.
Publicado: (2016)

ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey
por: Kreye, G., et al.
Publicado: (2022)

Postgraduate Curriculum in Dermatology: Expectations, Reality, and the Way Forward
por: Asokan, Neelakandhan
Publicado: (2021)

Nachwuchsförderung durch die European Society for Medical Oncology (ESMO): Erfahrungen aus dem ESMO Young Oncologist Committee (YOC)
por: Oing, Christoph, et al.
Publicado: (2020)

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
por: Dittrich, Christian, et al.
Publicado: (2016)

Current landscape of ESMO/ASCO Global Curriculum adoption and medical oncology recognition: a global survey
por: Cufer, T., et al.
Publicado: (2021)

The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe
por: Pavlidis, Nicholas, et al.
Publicado: (2016)

ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)
por: Ohe, Yuichiro, et al.
Publicado: (2017)

Indicators of integration at ESMO Designated Centres of Integrated Oncology and Palliative Care
por: Hui, David, et al.
Publicado: (2018)

Corrigendum to ‘Remembering Professor José Baselga’: [ESMO Open Volume 6, Issue 3, June 2021, 100121]
por: Tabernero, J.
Publicado: (2021)

Biosimilars in oncology
por: Tabernero, Josep
Publicado: (2018)

Educational needs in gastrointestinal cancer: a consensus position paper from the ESMO Gastrointestinal Cancer Faculty
por: Lordick, Florian, et al.
Publicado: (2019)

The ESMO position paper on biosimilars in oncology: enhancing the provision of accurate education and information
por: Schiestl, Martin, et al.
Publicado: (2017)

ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023
por: Cufer, Tanja, et al.
Publicado: (2023)

Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies
por: Berghoff, A.S., et al.
Publicado: (2021)

From ESMO 2022
por: Romero, Diana
Publicado: (2022)

Simultaneous Care in Oncology: A 7-Year Experience at ESMO Designated Centre at Veneto Institute of Oncology, Italy
por: Brunello, Antonella, et al.
Publicado: (2022)

Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey
por: Linardou, H., et al.
Publicado: (2023)

Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey
por: Banerjee, Susana, et al.
Publicado: (2018)

ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology—edition 2016
por: Dittrich, C., et al.
Publicado: (2016)

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
por: Gyawali, B., et al.
Publicado: (2021)

The hard way from the Beveridge to the Bismarck model of health finance: Expectations and reality in Russia
por: Shishkin, Sergey, et al.
Publicado: (2023)

All change: closing the gender gap in oncology
por: Tabernero, Josep
Publicado: (2018)

From ESMO TAT 2021
por: Killock, David
Publicado: (2021)

From the ESMO Congress 2021
por: Sidaway, Peter
Publicado: (2021)

ESMO Women for Oncology 2016: a very personal tale of my professional life in Asia
por: Thongprasert, Sumitra
Publicado: (2017)

The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration
por: Banerjee, S., et al.
Publicado: (2021)

President's page: ASPC is leading the way in preventive cardiology
por: Toth, Peter P.
Publicado: (2022)

ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers
por: Cherny, N I, et al.
Publicado: (2016)

Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey
por: Garrido, P., et al.
Publicado: (2021)

EHA evaluation of the ESMO—Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies
por: Kiesewetter, Barbara, et al.
Publicado: (2020)

ESMO 2017—my personal highlights
por: Kiesewetter, Barbara, et al.
Publicado: (2018)

My personal highlights of ESMO 2016
por: Dediu, M., et al.
Publicado: (2017)

Pain workshop ESMO: Africa (response)
por: Grant, Liz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fmovl1qhbh5lr2kkc7g5vcu7pf